Go Pro

Owlet (OWLT) Competitors

Owlet logo
$4.68 -0.01 (-0.11%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$4.84 +0.16 (+3.42%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OWLT vs. DCTH, TCMD, NPCE, SGHT, and CLPT

Should you buy Owlet stock or one of its competitors? Owlet's main competitors and comparable companies include Delcath Systems (DCTH), Tactile Systems Technology (TCMD), NeuroPace (NPCE), Sight Sciences (SGHT), and ClearPoint Neuro (CLPT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Owlet compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 19.4% of Delcath Systems shares are held by company insiders. Comparatively, 36.2% of Owlet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Delcath Systems has a net margin of 0.56% compared to Owlet's net margin of -8.61%. Delcath Systems' return on equity of 0.46% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Delcath Systems0.56% 0.46% 0.42%
Owlet -8.61%-601.24%-15.96%

Delcath Systems has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delcath Systems$95.42M5.79$2.70M$0.011,591.00
Owlet$114.41M1.20-$39.68M-$0.75N/A

In the previous week, Delcath Systems had 4 more articles in the media than Owlet. MarketBeat recorded 4 mentions for Delcath Systems and 0 mentions for Owlet. Delcath Systems' average media sentiment score of 0.58 beat Owlet's score of 0.36 indicating that Delcath Systems is being referred to more favorably in the media.

Company Overall Sentiment
Delcath Systems Positive
Owlet Neutral

Delcath Systems has a beta of 0.57, indicating that its share price is 43% less volatile than the broader market. Comparatively, Owlet has a beta of 1.9, indicating that its share price is 90% more volatile than the broader market.

Delcath Systems presently has a consensus price target of $23.17, indicating a potential upside of 45.61%. Owlet has a consensus price target of $15.00, indicating a potential upside of 220.17%. Given Owlet's higher probable upside, analysts clearly believe Owlet is more favorable than Delcath Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Delcath Systems
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.86
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

Delcath Systems beats Owlet on 12 of the 17 factors compared between the two stocks.

How does Owlet compare to Tactile Systems Technology?

Owlet (NYSE:OWLT) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

72.6% of Owlet shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 36.2% of Owlet shares are held by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Tactile Systems Technology had 5 more articles in the media than Owlet. MarketBeat recorded 5 mentions for Tactile Systems Technology and 0 mentions for Owlet. Tactile Systems Technology's average media sentiment score of 1.32 beat Owlet's score of 0.36 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company Overall Sentiment
Owlet Neutral
Tactile Systems Technology Positive

Owlet has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

Tactile Systems Technology has higher revenue and earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$114.41M1.20-$39.68M-$0.75N/A
Tactile Systems Technology$329.52M1.54$19.09M$1.0820.74

Owlet currently has a consensus price target of $15.00, suggesting a potential upside of 220.17%. Tactile Systems Technology has a consensus price target of $38.40, suggesting a potential upside of 71.43%. Given Owlet's higher possible upside, equities research analysts plainly believe Owlet is more favorable than Tactile Systems Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Tactile Systems Technology
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

Tactile Systems Technology has a net margin of 7.10% compared to Owlet's net margin of -8.61%. Tactile Systems Technology's return on equity of 11.49% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-8.61% -601.24% -15.96%
Tactile Systems Technology 7.10%11.49%9.17%

Summary

Tactile Systems Technology beats Owlet on 13 of the 16 factors compared between the two stocks.

How does Owlet compare to NeuroPace?

NeuroPace (NASDAQ:NPCE) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

In the previous week, NeuroPace had 3 more articles in the media than Owlet. MarketBeat recorded 3 mentions for NeuroPace and 0 mentions for Owlet. NeuroPace's average media sentiment score of 1.10 beat Owlet's score of 0.36 indicating that NeuroPace is being referred to more favorably in the media.

Company Overall Sentiment
NeuroPace Positive
Owlet Neutral

NeuroPace currently has a consensus price target of $19.29, suggesting a potential upside of 37.36%. Owlet has a consensus price target of $15.00, suggesting a potential upside of 220.17%. Given Owlet's higher probable upside, analysts plainly believe Owlet is more favorable than NeuroPace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeuroPace
1 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.78
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

NeuroPace has a beta of 1.94, indicating that its stock price is 94% more volatile than the broader market. Comparatively, Owlet has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market.

NeuroPace has higher earnings, but lower revenue than Owlet. NeuroPace is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeuroPace$106.99M4.50-$21.47M-$0.57N/A
Owlet$114.41M1.20-$39.68M-$0.75N/A

78.8% of NeuroPace shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 19.2% of NeuroPace shares are owned by company insiders. Comparatively, 36.2% of Owlet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Owlet has a net margin of -8.61% compared to NeuroPace's net margin of -19.34%. NeuroPace's return on equity of -105.64% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
NeuroPace-19.34% -105.64% -16.51%
Owlet -8.61%-601.24%-15.96%

Summary

NeuroPace beats Owlet on 11 of the 17 factors compared between the two stocks.

How does Owlet compare to Sight Sciences?

Sight Sciences (NASDAQ:SGHT) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

In the previous week, Sight Sciences had 2 more articles in the media than Owlet. MarketBeat recorded 2 mentions for Sight Sciences and 0 mentions for Owlet. Sight Sciences' average media sentiment score of 1.81 beat Owlet's score of 0.36 indicating that Sight Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Sight Sciences Very Positive
Owlet Neutral

Sight Sciences presently has a consensus target price of $7.88, suggesting a potential downside of 3.26%. Owlet has a consensus target price of $15.00, suggesting a potential upside of 220.17%. Given Owlet's higher possible upside, analysts clearly believe Owlet is more favorable than Sight Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sight Sciences
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Owlet has a net margin of -8.61% compared to Sight Sciences' net margin of -35.69%. Sight Sciences' return on equity of -43.39% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Sight Sciences-35.69% -43.39% -22.86%
Owlet -8.61%-601.24%-15.96%

Sight Sciences has a beta of 2.5, indicating that its stock price is 150% more volatile than the broader market. Comparatively, Owlet has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market.

Sight Sciences has higher earnings, but lower revenue than Owlet. Sight Sciences is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sight Sciences$83.38M5.38-$38.43M-$0.56N/A
Owlet$114.41M1.20-$39.68M-$0.75N/A

55.5% of Sight Sciences shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 30.4% of Sight Sciences shares are held by insiders. Comparatively, 36.2% of Owlet shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Sight Sciences beats Owlet on 9 of the 16 factors compared between the two stocks.

How does Owlet compare to ClearPoint Neuro?

Owlet (NYSE:OWLT) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

Owlet has a net margin of -8.61% compared to ClearPoint Neuro's net margin of -81.76%. ClearPoint Neuro's return on equity of -188.09% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-8.61% -601.24% -15.96%
ClearPoint Neuro -81.76%-188.09%-40.88%

ClearPoint Neuro has lower revenue, but higher earnings than Owlet. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$114.41M1.20-$39.68M-$0.75N/A
ClearPoint Neuro$42.28M9.90-$25.54M-$1.18N/A

In the previous week, ClearPoint Neuro had 3 more articles in the media than Owlet. MarketBeat recorded 3 mentions for ClearPoint Neuro and 0 mentions for Owlet. ClearPoint Neuro's average media sentiment score of 1.66 beat Owlet's score of 0.36 indicating that ClearPoint Neuro is being referred to more favorably in the news media.

Company Overall Sentiment
Owlet Neutral
ClearPoint Neuro Very Positive

72.6% of Owlet shares are held by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are held by institutional investors. 36.2% of Owlet shares are held by company insiders. Comparatively, 6.9% of ClearPoint Neuro shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Owlet has a beta of 1.9, indicating that its share price is 90% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Owlet currently has a consensus price target of $15.00, suggesting a potential upside of 220.17%. ClearPoint Neuro has a consensus price target of $25.67, suggesting a potential upside of 87.07%. Given Owlet's stronger consensus rating and higher probable upside, equities research analysts plainly believe Owlet is more favorable than ClearPoint Neuro.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
ClearPoint Neuro
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Owlet beats ClearPoint Neuro on 11 of the 16 factors compared between the two stocks.

Get Owlet News Delivered to You Automatically

Sign up to receive the latest news and ratings for OWLT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OWLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OWLT vs. The Competition

MetricOwletHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$137.05M$5.38B$7.13B$23.17B
Dividend YieldN/A1.79%2.56%3.56%
P/E Ratio-6.2525.09275.2428.71
Price / Sales1.2082.90656.0294.44
Price / CashN/A32.5377.0433.82
Price / Book6.605.9710.334.74
Net Income-$39.68M$150.75M$3.50B$1.07B
7 Day Performance-6.30%-2.83%-3.32%-2.00%
1 Month Performance-18.09%-3.09%-0.41%-2.69%
1 Year Performance-32.77%9.34%19.21%10.45%

Owlet Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OWLT
Owlet
2.5056 of 5 stars
$4.69
-0.1%
$15.00
+220.2%
-33.5%$137.05M$114.41MN/A106
DCTH
Delcath Systems
3.3688 of 5 stars
$16.40
-0.4%
$23.17
+41.3%
+42.9%$571.14M$85.23M1,641.6460
TCMD
Tactile Systems Technology
4.3098 of 5 stars
$22.25
-3.2%
$38.40
+72.6%
+63.4%$520.54M$350.31M20.601,086
NPCE
NeuroPace
3.4164 of 5 stars
$14.74
+0.6%
$19.29
+30.8%
+40.3%$502.85M$99.99MN/A170
SGHT
Sight Sciences
1.512 of 5 stars
$8.19
-3.6%
$7.88
-3.8%
+124.9%$468.25M$77.36MN/A210

Related Companies and Tools


This page (NYSE:OWLT) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners